AMPH
Amphastar Pharmaceuticals, Inc.
23.60$
-0.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -49.3% | +261.0% | +1.7% | -2.6% | +9.4% | +37.1% | +71.1% | -9.0% | +105.8% | +16.3% | -26.8% | |
| – | -8.3% | +9.9% | +6.0% | +7.0% | +27.9% | +19.2% | +6.2% | +7.4% | +45.4% | +36.9% | +10.5% | |
| – | +38.1% | +18.0% | +13.0% | -2.4% | +3.7% | +18.5% | -8.8% | -4.4% | +13.3% | +20.4% | +11.9% | |
| – | +5,313.2% | +209.9% | +46.3% | -10.5% | +37.0% | -10.0% | -60.9% | -66.0% | – | – | – | |
| – | -132.9% | – | +96.0% | +1,979.7% | -527.5% | – | -121.1% | – | – | – | – | |
| – | -21.7% | +33.2% | +64.2% | +33.4% | -11.2% | -18.5% | -18.9% | -12.5% | +58.8% | +7.5% | -15.0% | |
| – | -57.4% | +133.4% | -1.9% | +8.8% | +19.8% | -27.9% | -21.3% | +14.3% | +1,880.4% | -80.8% | -43.7% | |
| – | -61.0% | -49.7% | -100.0% | – | – | – | -31.3% | -1.7% | +2,800.1% | – | – | |
| – | +1,244.0% | +0.4% | +210.3% | -18.5% | -11.0% | +9.6% | +18.2% | +38.2% | +45.7% | +47.0% | -11.6% | |
| – | -108.8% | +101.9% | – | -66.9% | -204.5% | -72.6% | – | -107.2% | – | -98.1% | -41.1% | |
| – | -93.0% | +219.2% | -208.1% | – | -115.1% | -40.6% | +1,548.2% | -28.6% | – | -117.8% | -16.7% | |
| – | -112.3% | – | -207.6% | – | -161.0% | – | +69.2% | -7.3% | -139.7% | – | +153.9% | |
| – | -1,070.3% | – | -76.1% | -309.7% | – | +11,209.7% | +201.3% | -7.6% | +123.1% | +18.6% | -29.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.